Physician profile
Patrick Alan Grady
NPI 1578702569
$4,302.87
in general payments reported to CMS, 2019-2025
31 companies · $988 in 2025
The $988 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $691 · 2023: $1,186 · 2024: $1,307 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,481.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $737.92 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $608.12 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $518.00 | 2021-2025 | |
| Amgen INC. | $307.31 | 2022-2025 | Repatha, Otezla, Evenity |
| Gilead Sciences, INC. | $276.69 | 2023-2024 | |
| Glaxosmithkline, LLC. | $235.34 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $212.49 | 2022-2025 | Mounjaro, Zepbound |
| Mml US, INC. | $185.85 | 2023 | Reactiv8 |
| Novo Nordisk INC | $166.87 | 2023-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $161.71 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Hologic Sales and Service, LLC | $140.02 | 2022-2025 | Thinprep 2000 Processor, Aptima |
| Inogen, INC. | $107.16 | 2023-2025 | Inogen |
| Astellas Pharma US INC | $100.11 | 2023-2024 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.11 | 2022-2025 | Xifaxan, Trulance |
| Idorsia Pharmaceuticals US INC | $47.92 | 2022-2023 | Quviviq |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $44.30 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.06 | 2022-2023 | |
| Sunovion Pharmaceuticals INC. | $37.80 | 2021-2022 | |
| Lucid Diagnostics INC. | $36.54 | 2021-2022 | |
| Exact Sciences Corporation | $29.03 | 2025 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $26.96 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Electromed, INC. | $25.19 | 2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $23.85 | 2024 | Glassia |
| Vanda Pharmaceuticals INC. | $22.72 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $22.63 | 2021 | |
| Sumitomo Pharma America, INC. | $19.34 | 2025 | Gemtesa |
| Amneal Pharmaceuticals LLC | $17.36 | 2024 | Unithroid |
| Janssen Pharmaceuticals, INC | $16.56 | 2025 | Spravato |
| Amarin Pharma, INC. | $16.54 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $15.76 | 2024 | Dupixent |
| Biohaven Pharmaceutical Holding Company LTD. | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Grady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.